Dr. Anna Wilkinson, a family physician at the Ottawa Hospital with a special interest in oncology, has received a $10,000 clinical grant from Prostate Cancer Foundation Canada to research how changes in PSA screening recommendations have impacted prostate cancer outcomes in Canada.
To attend in person
- Please register early by e-mail at: .(JavaScript must be enabled to view this email address), and please ensure that you include the number of attendees in your party.
- By email, we’ll either confirm your reservation, or advise you that we’ve reached the Centre’s capacity of 24 persons
Note: Masks are not mandatory but are recommended in the Maplesoft-Jones Centre
To attend virtually by Zoom
- To register, please click on this link. After registering, you’ll receive an email with instructions for joining the meeting.
Our Guest Speaker Dr. Anna Wilkinson – PSA Screening Effects
Prostate cancer is the most frequently diagnosed cancer among Canadian men, excluding non-melanoma skin cancers, and remains a significant cause of cancer-related deaths. Early stage prostate cancer has excellent survival, but advanced stages see a marked decrease in survival.
Prostate-specific antigen (PSA) can be used to screen for prostate cancer, finding cases before they present with symptoms at a later stage. PSA screening is controversial due to concerns about over-diagnosis and unnecessary treatment. Over the years screening recommendations have evolved, influencing screening practices. It is important to monitor prostate cancer outcomes relative to screening recommendations to assess the impact of any recommendations.
This study aims to analyze Canadian Cancer Registry data to explore how changing recommendations for or against PSA screening have influenced prostate cancer outcomes. By examining trends in prostate cancer incidence, mortality, and stage distribution across age groups relative to screening guideline changes, the study will provide insights into whether the recommendation against prostate cancer screening has led to worse prostate cancer outcomes.
The findings will contribute to a better understanding of how prostate cancer screening guidelines impact prostate cancer detection and outcomes. Ultimately, this research aims to inform future guidelines to improve prostate cancer screening practices in Canada.
Curling News
We thank you for your continued support!
Not sure where to start?
We are only a phone call or email away. Contact PCSO anytime at 613-828-0762 or .(JavaScript must be enabled to view this email address).